跳至主要内容
临床试验/NCT00380523
NCT00380523已完成4 期

Analgesic Treatment Mediated by Arcoxia

Organon and Co0 个研究点目标入组 237 人开始时间: 2005年4月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
237
主要终点
Evaluate pain using the verbal analog scale (evaluate pain before starting treatment and then evaluate pain every day after had taken arcoxia up to three days)

研究概览

简要总结

Allow physicians to test the efficacy of arcoxia in patients with acute pain.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of acute pain susceptible of pharmacological treatment
  • Greater than 18 years of age
  • Voluntary acceptance to participate in the study and signature of the informed consent form

排除标准

  • Allergy to etoricoxib or any of its components
  • Less than 18 years old
  • Patient is taking anticoagulants
  • Patient that already has taken any drug as analgesic

结局指标

主要结局

Evaluate pain using the verbal analog scale (evaluate pain before starting treatment and then evaluate pain every day after had taken arcoxia up to three days)

次要结局

  • Patient satisfaction with the drug therapy using PGART scale
  • Patient satisfaction was obtained at the end of treatment(on third day)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验